Posted by Michael Wonder on 07 Dec 2021
Critics blame diabetes deaths on PHARMAC taking years to fund new drug
6 December 2021 - Diabetes Foundation Aotearoa says PHARMAC's delay funding new diabetes drugs has led to many deaths in Māori and Pasifika.
A report involved in a review of PHARMAC shows the agency was first asked to fund empagliflozin to treat type 2 diabetes in February 2015.
But it took almost six years for it to announce funding, along with dulaglutide, to treat an estimated 53,000 patients.
